Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05473130 · ClinicalTrials.gov registry record
Breethe Abiomed Recovery RegisTry (BART)
A clinical trial, sponsored by Abiomed.
- Completed
- Registry status
- 48
- Enrollment target
NCT05473130: Completed study, sponsored by Abiomed.
NCT05473130 is a clinical trial that has completed, run by Abiomed. The registered enrollment target is 48 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05473130 has completed, sponsored by Abiomed.
- COMPLETED
- Registry status
- 48 participants
- Enrollment target
Study Summary
The BART Registry intended to utilize observational data of the Abiomed Breethe OXY-1 System™ in real-world settings to drive best practice usage patterns, serve as a tool to measure and improve the quality of patient care and as a resource to inform us on the design of future studies.
Interventions
- DEVICE Breethe Oxy-1 System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2021-03-31 |
| Est. Completion | 2024-04-02 |
What the finished NCT05473130 record still lists
NCT05473130 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 48 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Breethe Oxy-1 System is the first listed.
NCT05473130 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05473130 about?
NCT05473130 is a clinical study titled "Breethe Abiomed Recovery RegisTry (BART)". The BART Registry intended to utilize observational data of the Abiomed Breethe OXY-1 System™ in real-world settings to drive best practice usage patterns, serve as a tool to measure and improve the quality of patient care and as a resource to inform us on the design of future studies.
What is the current status of trial NCT05473130?
This trial is currently completed. The enrollment target is 48 participants. The study started on 2021-03-31. Estimated completion is 2024-04-02.
What interventions are being tested in trial NCT05473130?
The interventions under investigation include: Breethe Oxy-1 System (DEVICE).
Who is sponsoring clinical trial NCT05473130?
This trial is sponsored by Abiomed, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI